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Intermolecular and Intramolecular Interactions Controlling the Localization and 
Activity of the Yeast Kinases Kin1 and Kin2 
 
 





Kin1 and Kin2 (Kin1/2), the S. cerevisiae orthologs of the mammalian microtubule 
affinity-regulating kinases (MARKs), regulate a variety of important cellular functions, 
including exocytosis and the unfolded protein response (UPR).   In this study, I examined 
the regulation of Kin1/2 kinase activity and localization, which are poorly understood.  I 
determined the impact on Kin1/2 of interaction with Bud14, a regulatory subunit of the 
phosphatase Glc7, the budding yeast ortholog of PP1.  Kin1/2 localization to sites of 
polarized growth was completely dependent on interaction with Bud14, although Kin1/2 
kinase activity was not dependent on Bud14.  I also examined the impact of the kinase-
associated 1 (KA1) domain on both the kinase activity and localization of Kin1/2.  
Mutation of the KA1 domain had a partial effect on Kin1/2 localization.  The KA1 domain 
also autoinhibits Kin1/2 catalytic activity, and mutation of the KA1 domain increases 
Kin1/2 activity nearly ten-fold.  Kin1/2 kinase activity is also profoundly impacted by 
activation loop phosphorylation of a conserved threonine residue, which increases Kin1/2 
kinase activity by 20-fold.  I found that the protein kinases Elm1, Sak1 and Tos3, which 
activate related kinases, are responsible for Kin1/2 activation loop phosphorylation.  The 
level of kinase activity, but not localization, is vital for Kin1/2 function in the unfolded 
protein response.  Taken together, these results further elucidate the mechanisms 
controlling cellular Kin1/2 activity and localization.         
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AGC Protein Kinase A, Protein Kinase G, Protein Kinase C group                                                         
AMP Adenosine monophosphate                 
AMPK AMP-activated protein kinase              
ATP Adenosine triphosphate  
CAMK Ca2+/Calmodulin dependent protein kinase 
CK1 Casein kinase 1 
CK2 Casein kinase 2 
CUG 3-carboxyumbelliferyl β-D-galactopyranoside 
ER Endoplasmic reticulum 
FDG Fluorescein di-β-D-galactopyranoside 
GFP Green fluorescent protein 
GPCR G-protein coupled receptor 
GSK3 Glycogen synthase kinase 3 
IP3 Inositol trisphosphate 
KA1 Kinase-associated 1 domain 
kDa Kilodalton 
LKB1 Liver kinase B1 
MAPK Mitogen-activated protein kinase 
MAPKK MAPK kinase 
MAPKKK MAPKK kinase 
MAPKKKK MAPKKK kinase 
MARK Microtubule affinity-regulating kinase 
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mTOR Mammalian target of rapamycin 
NLS Nuclear localization sequence 
PCR Polymerase chain reaction 
PH Pleckstrin homology 
PIP2 Phosphatidylinositol 4,5 bisphosphate  
 
PIP3 Phosphatidylinositol 3,4,5 bisphosphate 
PKA Protein kinase A 
PKC Protein kinase C 
PM Plasma membrane domain 
RT Room temperature 
RTK Receptor tyrosine kinase 
SC Synthetic complete 
SDS Sodium dodecyl sulfate 
SH2 Src homology 2 domain 
SH3 Src homology 3 domain 
TAOK1 Thousand-and-one kinase 1 
TCA Trichloroacetic acid 
UBA Ubiquitin-associated domain 











Protein kinases play necessary roles in every aspect of a living cell.  From 
controlling metabolism, growth and division, to confronting stresses and adverse 
conditions, kinases are vital to cellular regulation at many levels.  It is also important to 
understand not only how kinases regulate the cell, but how kinases themselves are 
regulated.  Effective signal transduction in cells requires that kinases become activated at 
the appropriate location and time, and that they are switched off when the activating signal 
is no longer present.  Unregulated kinase activity can lead to cellular dysfunction and can 
be a cause of disease.   
One family of kinases that plays important roles in eukaryotic cells is the AMP-
activated protein kinase related (AMPKR) family1.  AMPKRs comprise a branch of the 
Ca2+/calmodulin-dependent protein kinase-related (CAMK) group, and are conserved 
across all eukaryotic kingdoms2.  The family is defined based on sequence similarity 
within an N-terminally located catalytic kinase domain, with their C-terminal regions 
consisting of regulatory domains that vary among family members (Fig 1.1).  The best-
studied member of the family is AMPK, a major regulator of cellular metabolism1.  Other 
AMPKR subfamilies include the Brsk, Nuak, and the MARK/Par1/Kin1 groups2.  My 
dissertation focuses on the MARK/Par1/Kin1 subfamily.  Members of the subfamily in 
mammals are known as microtubule affinity-regulating kinases (MARKs), and orthologs 












Figure 1.1:  AMPKR family protein kinases in Saccharomyces cerevisiae.   
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kin1 in S. pombe, and Kin1 and Kin2 (Kin1/2) in S. cerevisiae3-12.  MARK/Par1/Kin1 
kinases are highly conserved across eukaryotes, with ~35-40% sequence identity between 
orthologs from yeast and humans.  The kinases share a structural similarity, with their N-
terminal kinase domains followed by a ubiquitin-associated domain UBA domain, a long, 
poorly conserved central region, and a C-terminal kinase-associated 1 (KA1) domain (Fig 
1.2)13, 14.  Along with their structural similarity, the MARK/Par1/Kin1 subfamily share 
common functions, as many of them are implicated in the establishment of cell polarity15.  
For example, C. elegans Par1 was first identified as essential for establishing a polar axis 
during early embryonic development, and S. pombe kin1 works in conjunction with several 
other proteins to establish polarity and maintain cellular symmetry4, 16.  Given the role of 
the MARK/Par1/Kin1 subfamily in such an important cellular process, it is not surprising 
that the dysfunction of these kinases can have dire implications for organisms.  The human 
MARKs are believed to participate in the development of Alzheimer’s disease by 
hyperphosphorylation of their substrate Tau, which can promote the formation of 
neurofibrillary tangles17, 18.  MARKs are also implicated in various cancers, with some 
isoforms upregulated in brain cancers, and other isoforms downregulated or inactivated in 
lung cancers and stomach cancers19-21.  MARKs are also important effectors of the tumor 
suppressor LKB1.     
Given the importance of MARK activity and the fact that dysregulation of MARKs 
can lead to disease, it is necessary for cells to regulate these kinases.  Many kinases are 
activated by phosphorylation in the activation loop, a flexible region in the C-terminal lobe 
of the catalytic domain22.  Canonical activation loop phosphorylation serves to stabilize the 





















Figure 1.2:  Domain map of S. cerevisiae Kin1 (1064 amino acids) and Kin2 (1147 amino 
acids).  Kin1/2 are representative of MARK/Par1/Kin1 kinases, with an N-terminal Ser-Thr 
kinase catalytic domain depicted in red (residues 120-398 in Kin1, 99-377 in Kin2) and a C-
terminal kinase-associated 1 (KA1) domain, depicted in blue (residues 1015-1064 in Kin1, 
1098-1147 in Kin2). 
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conformation by promoting substrate binding as well as proper alignment of the active site.  
Activation loop phosphorylation can also affect positioning of the αC helix, inducing its 
conserved glutamic acid residue to ion pair with the catalytic lysine in the AxK motif.  
AMPKR family members, including the MARK/Par1/Kin1 subfamily, are activated by 
phosphorylation of a conserved threonine residue in the activation loop.  Activation loop 
phosphorylation of the MARK/Par1/Kin1 subfamily is mediated by conserved activators: 
liver kinase B1 (LKB1) and thousand and one kinase (TAOK1) in mammals, Par4 in C. 
elegans, and ssp1 in S. pombe23, 24.  The S. cerevisiae orthologs, Elm1, Sak1 and Tos3, are 
known to activate some members of the AMPKR family, although the activating kinases 
of Kin1/2 remain unidentified25-29.    
MARK activity is also regulated by controlling access to the catalytic cleft of the 
kinase.  The MARK/Par1/Kin1 subfamily contains a conserved C-terminal KA1 domain 
that binds to the catalytic domain and occludes substrate binding30, 31.  In mammalian 
MARKs, the KA1 domain can reduce kinase activity toward a peptide substrate by more 
than 50%.  Some strains of the H. pylori bacteria that cause stomach ulcers and cancers 
secrete the CagA protein, which binds to and occludes the catalytic cleft of MARKs 
through a pseudosubstrate interaction32, 33.  CagA thus acts as an inhibitor of the kinase, 
increasing the cell polarity defects of affected cells and increasing the carcinogenic 
potential of the H. pylori strains that express CagA19.   
Substrate recognition is another important factor impacting MARK activity.  In 
order to faithfully promulgate a signal in the proper pathway, a kinase must exhibit 
specificity for its appropriate substrates.  Like all members of the CAMK kinase group, 
AMPKR family kinases are serine-threonine kinases that generally have a strong 
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preference for an arginine residue three residues upstream of the phosphoacceptor, known 
as the “-3” position.  Preference for the -3 basic residue is mediated by formation of a salt 
bridge with a conserved glutamic acid residue in the catalytic cleft34.  AMPKRs also 
preferentially phosphorylate substrates with a hydrophobic residue five residues upstream 
(-5) and four residues downstream (+4) of the phosphoacceptor.  Selectivity at the -5 
position has been revealed by crystallographic and mutational analysis to be driven by four 
residues that form a hydrophobic pocket to accommodate the hydrophobic sidechain35.  The 
preference of all AMPK family kinases for a +4 hydrophobic residue is mediated by the 
unique presence of an alanine residue immediately upstream of the APE motif in the 
activation loop (AAPE).  In other serine-threonine kinases, this residue is typically Leu, 
Met or Arg. The small Ala residue in AMPKRs creates a hydrophobic cavity that allows 
binding of the +4 residue (usually Leu or Val).   
Binding to lipids through non-catalytic domains is a common means of localizing 
kinases within the cell, with prominent examples including AKT and PKC.  The KA1 
domain of the MARK/Par1/Kin1 kinases, in addition to inhibiting the catalytic domain, 
binds anionic phospholipids and helps to localize them to cell membranes36, 37.  The binding 
of the KA1 domain to phospholipids may also serve to release its autoinhibitory 
interactions with the catalytic domain, thus serving to increase kinase activity locally.  
Increasing the activity of the kinase while simultaneously localizing it within the cell 
provides a convenient means to direct the activity of the MARKs in an efficient way.  This 
idea is reinforced by the fact that the same cluster of basic residues of the KA1 domain that 
mediate autoinhibition of the kinase also interact with phospholipids.  Another example of 
regulation of kinase activity by interaction with lipids is protein kinase C (PKC).  PKC is 
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activated by phosphorylation of its activation loop, and binds diacylglycerol (DAG) at the 
plasma membrane in response to cleavage of phosphatidylinositol (4,5) bisphosphate 
(PIP2)38.  This produces DAG which promotes PKC localization to the plasma membrane, 
but also liberates inositol triphosphate 3 (IP3), a second messenger that leads to activation 
of the PKC molecules now located at the plasma membrane.    
MARK/Par1/Kin1 localization may also be regulated by phosphorylation at sites 
outside of the catalytic domain and by interaction with protein binding partners.  For 
example, phosphorylation of human MARKs by PKC impacts their localization.  PKC 
phosphorylation creates a binding site for 14-3-3 proteins, which sequester the MARKs in 
the cytoplasm, away from peripherally localized substrates, and serve to inhibit kinase 
activity39, 40.  MARKs are also known to interact with Gab1, a scaffold protein that 
increases kinase activity of the MARKs by preventing the KA1 domain from binding to 
the active site of the kinase41.  In S. pombe, kin1 is localized to the sites of polarized growth 
by a combination of the KA1 domain, which assists with membrane localization in general, 
and by its association with pal1, a protein binding partner.  pal1 is also a substrate of kin1, 
and co-localizes with it to the tips of growing cells.  kin1 and pal1 are mutually dependent 
for localization to these polar sites.  In addition to pal1, kin1 localization to sites of 
polarized growth is also aided by tea4, a regulatory subunit of dis2, the fission yeast 
ortholog of protein phosphatase-1 (PP1).  It is unknown whether the KA1 domain of S. 
cerevisiae Kin1/2 plays a role in membrane localization, or if Kin1/2 interact with protein 
binding partners that determine their distribution within the cell, questions that I will 
address in this dissertation. 
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The subsequent research in this study is concerned with the budding yeast 
Saccharomyces cerevisiae AMPKR family, in particular with the members of the 
MARK/Par1/Kin1 subfamily, Kin1 and Kin2.  The yeast AMPKR family has six members.  
Snf1, the best characterized member of the family, is orthologous to mammalian AMPK, 
and as such fulfills the same role in the cell of acting as a master regulator of metabolism.  
Three other members of the family, Gin4, Kcc4, and Hsl1, have roles in septin organization 
during cell division, consistent with the AMPKR family role in establishment of cell 
polarity.  Hsl1 in particular participates in the bud morphogenesis checkpoint, coupling 
proper septin formation to cell cycle progression by mediating degredation of the Cdc28 
kinase Swe142, 43.  Each of these family members is activated by phosphorylation of a 
conserved threonine by some combination of Elm1, Sak1, or Tos3, all of which are 
orthologs of LKB1/Par4/Ssp1.  The final two family members and the closest budding 
yeast homologs of animal MARK/Par1 kinases are Kin1 and Kin29, 44.     
While Kin1 and Kin2 (Kin1/2) were first cloned more than 30 years ago, 
comparatively little is known about their function or regulation.  An issue that limits 
understanding the function of Kin1/2 has been the lack of a phenotype under normal growth 
conditions when both kinases are deleted.  One role for Kin1/2 was discovered through a 
high-copy suppressor screen for secretory pathway mutants45.  Overexpression of Kin1 or 
Kin2 rescued the temperature-sensitive growth defect of late secretory pathway mutant 
strains, suggesting a role for Kin1/2 in exocytosis.  This research also revealed that Kin1/2 
directly interact with and phosphorylate Sec9, a t-SNARE protein involved in vesicle 
fusion.  Kin1/2 phosphorylation of Sec9 leads to its dissociation from the plasma 
membrane, and an increase in the cytosolic pool of Sec9, which presumably aids in Sec9 
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incorporation into vesicles ready for fusion during exocytosis.  There is also evidence of 
an interaction between Kin2 and Rho3, a GTPase that plays a critical role in exocytosis as 
well as cell polarity46.  It is unclear if the function of Kin1/2 in exocytosis is related to a 
broader function in establishing cell polarity, and no role for endogenous Kin1/2 in 
regulating exocytosis has been described.   
Kin2 was also reported to localize to sites of polarized growth, an interesting 
observation given the role of orthologous proteins in establishing cell polarity in other 
organisms.  In budded cells, GFP-tagged Kin2 was found to localize to the bud neck and 
bud tip, and also displayed more general localization to the cell cortex46, 47.  Structure-
function analysis determined that two regions within Kin2 were important for localization.  
The N-terminal portion of the protein (residues 1-510) including the catalytic domain was 
necessary for localization to sites of polarized growth, although the Kin2 signal detected at 
the bud tip was reduced for this construct.  The KA1 domain was found to be necessary for 
general localization to the plasma membrane but dispensable for localization to sites of 
polarized growth.  It was also found that the ability of Kin2 to localize to sites of polarized 
growth was necessary for proper function in exocytosis.  However, mechanisms controlling 
this localization have not been uncovered.   
Kin1/2 also play a role in proper cell wall organization.  KIN2 overexpression 
caused a minor defect in cell morphology and budding46.  Overexpression of Kin2 also 
sensitized budding yeast to cell wall disrupting agents such as SDS and calcofluor white.  
This phenomenon was also observed upon overexpression of a Kin2 mutant lacking an 
intact KA1 domain, a notable result given the role of the KA1 domain in localizing MARKs 
to cell membranes.  Chitin staining of the cell wall suggests that overexpression of Kin2 
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leads to a defect in cell wall organization.  The same N-terminal region of Kin2 (residues 
1-510) that is necessary for localization to sites of polarized growth suppressed growth 
when overexpressed.  The kinase activity of Kin2 was required for this growth suppression.  
Likewise, Kin2 lacking a KA1 domain failed to support growth when overexpressed.  Kin2 
was also found to interact with Tos1, a protein known to bind the cell wall, perhaps 
explaining the cell wall disorganization results.  The N-termin of Kin2 interacted with 
Bmh1, a 14-3-3 protein in budding yeast.  Given the important regulatory nature of the 
interaction between the human MARKs and 14-3-3 proteins, this interaction suggests that 
14-3-3 binding may be a more general means of regulating the MARK/Par1/Kin1 family.  
All of these results imply that there may be deeper role for Kin1/2 in cell polarity, despite 
the lack of an observable phenotype in kin1∆ kin2∆ strains.        
Several interactions between Kin2 and other proteins have also been discovered 
that provide insight into Kin2 function in proper septin formation and regulation of the cell 
wall.  These interactions also hint at an overall function for Kin2 in establishing cell 
polarity.  As mentioned, KIN2 overexpression causes a minor defect in cell morphology 
and budding, an effect that was exacerbated in a strain lacking GIN446.  This is noteworthy 
given the role of Gin4 in proper septin organization during budding.  Kin2 was found to 
interact with Cdc11, a septin subunit in budding yeast.  Kin2 also interacted with Pea2, a 
protein that is a component of the polarisome and also believed to function in septin 
formation.  Both of these interactions occurred in the same region of Kin2 (residues 780-
1147).  Overexpression of this region alone lead to septation defects in yeast, suggesting 
that the interaction with one or both of these proteins could be responsible for the septation 
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defects observed.  A role for Kin2 in septin regulation would also indicate a role in 
cytoskeletal regulation congruous with MARK/Par1/Kin1 family members across species.   
More recently, it has come to light that combined deletion of KIN1 and KIN2 
strongly sensitizes cells to agents such as tunicamycin and DTT that cause ER stress and 
stimulate the unfolded protein response (UPR)48, 49.  The UPR, the only ER stress pathway 
in yeast, is activated by the dual kinase/RNAse Ire1.  When Ire1 detects misfolded protein 
in the lumen of the ER, it forms foci and cleaves introns from HAC1 mRNA (orthologous 
to XBP1 mRNA in humans).  HAC1 mRNA is actively targeted to Ire1 to begin this process.  
This spliced HAC1 is translated into Hac1 protein, which is translocated into the nucleus 
to act as a transcription factor that leads to the production of a number of genes that assist 
with resolving ER stress and protein folding.  Kin1/2 kinase function is necessary for 
function in the UPR.  Overexpression of Kin1/2 was able to overcome targeting defects 
associated with a mutant variant of HAC1 mRNA.  Deletion of both KIN1 and KIN2 
disrupts multiple processes in the UPR, from Ire1 foci formation to the targeting of HAC1 
mRNA to Ire1. It remains unclear exactly how Kin1/2 promote the UPR, or what 
substrate(s) they phosphorylate to mediate this response.    
One interesting feature of Kin1/2 is that they possess a unique phosphorylation 
motif preference relative to the other yeast AMPKRs50, 51.  The other four members of the 
family recognize a motif similar to human AMPK, with a preference for an arginine residue 
at the -3 position, as well as a preference for a hydrophobic amino acid at the -5 and +4 
position relative to the phosphoacceptor (Fig 1.3).  Among these features, Kin1/2 only 
share a preference for a hydrophobic residue at the +4 position, in keeping with the 






















Figure 1.3:  Canonical phosphorylation motifs of AMPKR family kinases (top row) and S. 
cerevisiae Kin1 and Kin2 (bottom).  The phosphoacceptor is indicated in red.   
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family members.  However, in contrast to essentially all members of the larger CAMK 
group, Kin1/2 lacks a basophilic preference at the -3 position.  In other kinases, the 
preference for a -3 Arg is mediated by a key Glu residue (Glu100 in human AMPK), which 
forms a salt bridge with the charged headgroup of the basic residue.  In Kin1/2, this Glu 
residue is substituted with Gln (Gln230 in Kin1, Gln209 in Kin2), neutralizing the charge 
and rendering Kin1/2 non-selective at the -3 position.  It is not immediately apparent why 
Kin1/2 lack a preference for a -5 hydrophobic residue in their substrates.  Residues that 
make contact with the -5 residue in other AMPKR family members are largely conserved 
in Kin1/2.  However, unlike other members of the family, two of these residues are 
isoleucine in Kin1/2.  It is possible that these larger branched hydrophobic residues occlude 
the -5 interaction pocket, preventing access by larger residues.  In addition, Kin1/2 have a 
lysine residue in the vicinity of the -5 interaction site, and the positive charge may preclude 
binding of a hydrophobic -5 residue.  Kin1/2 also show a unique preference for an 
asparagine residue two positions upstream (-2) and a phosphorylated serine/threonine 
residue two residues downstream (+2) of the phosphoacceptor51.  Kin1/2 activity against a 
peptide substrate is increased by ~25 fold when the substrate is phosphorylated at the +2 
position.  This phenomenon whereby a kinase recognizes a previously phosphorylated 
substrate is known as substrate priming or hierarchical phosphorylation.  Substrate priming 
is an established method of regulating kinase activity on a substrate, as it requires an extra 
input for phosphorylation to occur.  Some kinases, such as glycogen synthase kinase 3 
(GSK3) and Cdc7, recognize primed substrates through structural determinants in their 
kinase catalytic domain.52-55.  The Turk laboratory previously found that a patch of basic 
residues in the αC helix and the αC helix-β3 loop of Kin1/2 are positioned to interact with 
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the +2 residue on the substrate.  Mutational analysis of these residues revealed that Lys183 
and Arg187 in Kin1 (corresponding to Lys162 and Arg166 in Kin2) were required for 
Kin1/2 recognition of primed substrates.  Mutation of both of these residues to alanine 
reduced the activity of Kin1/2 on primed substrates to the same levels they exhibited on 
unprimed substrates.  It is interesting to note that the basic residues needed for Kin1/2 
recognition of primed substrates are conserved through most yeast species, although they 
are not conserved in the human MARKs, which lack a preference for primed substrates56.  
It was found that the ability to recognize primed substrates is necessary for optimal Kin1/2 
function in the UPR, particularly at high concentrations of tunicamycin, although it is 
dispensable for Kin1/2 function in exocytosis.   
While these recent insights have increased our understanding of Kin1/2, there is 
still much we do not understand about these kinases.  While it is known that Kin1/2 are 
activated by phosphorylation at a conserved threonine in the activation loop, it is not known 
what kinase(s) is responsible for activation at this site.  It is unclear what role the KA1 
domain plays in Kin1/2 regulation.  Does the KA1 domain autoinhibit the kinase domain 
of Kin1/2 as it does for the human MARKs?  Does it assist with localization of the kinase 
to sites of polarized growth?  Further, are there other factors that assist with Kin1/2 
localization to sites of polarized growth, such as interaction with Bud14?  High-throughput 
analyses have hinted at an interaction between Kin1/2 and Bud14, the budding yeast 
ortholog of tea4.  However, an interaction between Kin1/2 and Bud14 has never been 
independently verified, and it is unknown what impact Bud14 has on Kin1/2 localization 
or kinase activity.  Furthermore, how does localization and kinase activity impact the 
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function of Kin1/2 in the unfolded protein response.  The goal of this study is to answer 




Chapter 2: Intermolecular and intramolecular 
interactions controlling the localization and activity of 
the yeast kinases Kin1 and Kin2 
 
BACKGROUND 
 Protein kinases play a vital role in controlling a wide variety of cellular processes 
within all living organisms.  In order to function in normal physiology, the activity of 
kinases must be tightly regulated, as evidenced by the pathological impact of kinase 
hyperactivation in cancer and other human diseases. Numerous mechanisms exist within 
cells to regulate kinases. Perhaps the most common form of regulation is through 
phosphorylation by upstream kinases or through autophosphorylation, which typically 
increases the intrinsic catalytic activity of a kinase.  About two-thirds of human kinases, 
for example, are established or predicted to be activated by phosphorylation at conserved 
residues within the activation loop, a conformationally flexible region in the catalytic 
domain. Many kinases are regulated by intra- and/or intermolecular interactions between 
the catalytic domain and other regions of the protein. Finally, localization of kinase to 
specific areas or compartments of the cell can target kinases to spatially restricted pools of 
their substrates.  These mechanisms are not mutually exclusive, and often act in 
cooperation.   
 Microtubule affinity-regulating kinases (MARKs, also called Par1) are a group of 
serine-threonine kinases conserved throughout eukaryotes3.  Based on similarity within 
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their catalytic domains, MARK/Par1 kinases belong to the AMP-activated kinase related 
(AMPKR) family2.  MARK/Par1 orthologs across species include the MARKs in 
mammals, Par1 in C. elegans and D. melanogaster, kin1 in S. pombe and Kin1 and Kin2 
(Kin1/2) in S. cerevisiae4-12.  The MARK/Par1 kinases contain an N-terminal catalytic 
kinase domain, a kinase-associated 1 (KA1) domain at their C terminus, and a large, poorly 
conserved central region of unknown structure.  All isoforms are activated by 
phosphorylation of a key activation loop threonine residue.  Activation loop 
phosphorylation of mammalian MARKs is catalyzed by the tumor suppressor liver kinase 
B1 (LKB1) or thousand-and-one kinase (TAOK1)23, 24.  Additionally, the KA1 domain 
regulates kinase activity by autoinhibiting the kinase domain30, 31, 57.  The KA1 domain also 
binds to anionic phospholipids, and as such may play a role in localization of MARKs to 
the plasma membrane36.  It has been suggested that binding of the KA1 domain to the 
plasma membrane could couple localization to activation of the kinase.  In multicellular 
organisms, MARKs are also regulated by interactions with binding partners such as 14-3-
3 proteins, which serve to disrupt membrane localization of the MARKs in response to 
aPKC phosphorylation39.     
 In multicellular organisms, MARKs have an important role in establishing and 
maintaining epithelial cell polarity3.  This study focuses on the budding yeast MARK/Par1 
orthologs Kin1/29.  Kin1/2 peripherally associate with the plasma membrane, with Kin2 
reportedly localizing specifically to sites of polarized growth46, 47.  While Kin1/2 are 
members of the AMPKR family based on similarity within their catalytic domain, Kin1/2 
phosphorylate a divergent motif compared to other members of the family50.  Typical 
AMPKRs are basophilic and have a strong preference for substrates with an Arg residue 
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three positions upstream (-3) of the phosphoacceptor, and for hydrophobic amino acids five 
residues upstream (-5) and four residues downstream (+4) of the phosphoacceptor.  While 
Kin1/2 share the preference for the +4 hydrophobic residue with other family members, 
analysis of peptide substrates revealed that they prefer to phosphorylate sites with an Asn 
two residues upstream of the phosphoacceptor (-2), and a phosphorylated Ser or Thr 
residue two positions downstream (+2).  This preference for phosphorylated, or “primed” 
substrates is a method of regulation that has been reported in other kinases such as glycogen 
synthase kinase 3 (GSK3), Cdc7, and the casein kinases52-55, 58, 59.  Structural analysis using 
human MARK2 bound to a pseudosubstrate as a model determined that a cluster of basic 
residues in the αC helix and the β3-αC helix loop interact with the primed residue on the 
substrate51.  Mutation of these basic residues (Lys183/Arg187 in Kin1 or Lys162/Arg166 
in Kin2) created mutants that abolished the preference for phosphorylated substrates while 
maintaining activity towards unphosphorylated substrates.        
Kin1/2 have ascribed roles in several cellular processes.  A high-copy suppressor 
screen of secretory pathway mutants revealed that Kin1/2 play a role in exocytosis, where 
they promote fusion of exocytic vesicles with the plasma membrane through 
phosphorylation of the t-SNARE protein Sec945.  The role of Kin1/2 in exocytosis appears 
to be dependent on localization to the plasma membrane. Overexpression of Kin2 also 
leads to defects in septin organization, particularly in conjunction with deletion of the 
septin-regulating kinase Gin446.  Kin2 overexpression furthermore impairs chitin 
deposition at the cell wall and sensitizes yeast to cell wall disrupting agents such as SDS 
and calcofluor white.  Recently it was reported that Kin1/2 are important for promoting the 
ER stress-mediated unfolded protein response (UPR)48, 49.  Kin1/2 are believed to promote 
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processing of Hac1 mRNA by the ER resident transmembrane kinase/RNAse Ire1 to 
produce the mature Hac1 transcription factor.  Further, deletion of both Kin1 and Kin2 
sensitizes budding yeast to ER stress agents such as tunicamycin.  The kinase activity of 
Kin1/2 is necessary for function in the UPR, and the ability of Kin1/2 to recognize primed 
substrates is required for optimal function, especially at high concentrations of 
tunicamycin.  It is unclear if Kin1/2 participation in the UPR is related to other cellular 
functions of Kin1/2, such as exocytosis.   
In this study I investigate how Kin1/2 localization and activity are influenced by 
interaction with the protein Bud14. No fewer than four large scale protein interaction 
screens have detected an interaction between Bud14 and/or Kin1 and Kin2, although the 
interaction has never been independently confirmed60-63. Bud14 is a regulatory subunit of 
the phosphatase Glc7, the budding yeast ortholog of PP164.  Bud14 is a 79 kDa protein 
containing a central SH3 domain important in the establishment of polarized growth.  
Bud14 localizes to sites of polarized growth through an interaction with the Kelch proteins 
Kel1 and Kel2, where it participates in cell polarization in at least two ways65, 66. First, it 
acts as an inhibitor of the formin Bnr1 to locally regulate actin dynamics67, 68. By acting as 
an adapter subunit for Glc7, Bud14 promotes local activation of the dynein/dynactin 
complex to impact microtubule dynamics69.  Bud14 also functions in other pathways that 
share a role in regulating polarity, such as MAPK pathways controlling mating and 
filamentous growth.  Bud14 deletion confers sensitivity to mating pheromone, aberrant 
formation of mating projections, hyperpolarized growth of projections during filamentous 
growth. The connection between Bud14 and Kin1/2 is supported by observations that in S. 
pombe, deletion of the single Kin1/2 ortholog kin1 exacerbates the aberrant growth 
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phenotype associated with mutants of the Bud14 ortholog tea470. Furthermore, a 
phosphoproteomics study demonstrated kin1-dependent phosphorylation of tea4 in vivo, 
though whether this is functionally important is unknown16.      
Given the limited knowledge of both the function and regulation of Kin1/2 in 
budding yeast, I investigated regulation of the activity and localization of budding yeast 
Kin1/2.  Of particular interest was the impact of interaction with the putative protein 
binding partner Bud14 on Kin1/2 localization to sites of polarized growth, and whether 
Kin1/2 localization was also mediated by the KA1 domain, as is the case with the 
mammalian MARKs.  I also investigated the impact of both activation loop 
phosphorylation and KA1-mediated autoinhibition of Kin1/2 kinase activity.  I established 
that Bud14 interacts with two discrete regions of Kin1/2 to localize the kinases to sites of 
polarized growth.  I also found that the KA1 domain promotes proper localization of 
Kin1/2, and also regulates their kinase activity.  I also examined the extent to which 
activation loop phosphorylation increases Kin1/2 kinase activity and identified the 
responsible upstream kinases. Disruption of proper Kin1/2 localization did not impact its 
ability to function in the UPR. However, regulation of Kin1/2 kinase activity by either the 
KA1 domain or activation loop phosphorylation influenced its capacity to support growth 
under conditions of ER stress.  Thus, Kin1/2 kinase activity, but not localization, correlates 
with Kin1/2 function in the UPR.  
 
RESULTS 
Kin1 and Kin2 localize to sites of polarized growth in a manner dependent on Bud14 
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It has been reported previously that Kin2 localizes partly to sites of polarized growth in 
budding yeast46. To compare the localization patterns of Kin1 and Kin2, I expressed them 
as GFP fusion proteins from their native promoters on low-copy plasmids and visualized 
them by fluorescence microscopy.  As previously reported, I found that in a subset of cells, 
GFP-Kin2 localized to sites in a diffuse manner at the bud neck or bud tip (Fig 2.1).  GFP-
Kin1 localized to the same regions, but in some cells formed bright puncta at the cell 
periphery (Fig 2.2). Bud14 reportedly interacts with Kin1/2 and has a similar pattern of 
localization60-63, 65.  We therefore examined whether localization of Kin1 or Kin2 was 
dependent on Bud14.  We found that in a bud14Δ strain, neither Kin1 nor Kin2 localized 
to sites of polarized growth (Fig 2.3).  Re-expression of mCherry-tagged Bud14 rescued 
Kin1-GFP localization in the bud14Δ strain (Fig 2.4).  Furthermore, we observed complete 
co-localization of mCherry-Bud14 with Kin1-GFP (Fig 2.5). These observations are 
consistent with Bud14 having a role in controlling the subcellular localization of Kin1. 
 
Proper localization of Kin1/2 requires a direct physical interaction with Bud14 
While large scale screens have implicated Kin1/2 and Bud14 as interaction partners, they 
have also uncovered a number of common interactors for the two proteins, including 
Kel1/2, Swe1, Dhh1, and Glc760-63, 66. It is plausible that Bud14 influences Kin1/2 
localization indirectly through an intermediary protein. To examine the importance of a 
direct Bud14-Kin1/2 interaction, we sought to map their region(s) of interaction using a 


























Figure 2.1:  Localization of GFP-Kin2 to bud tip (left) and bud neck (right) in dividing yeast 


























Figure 2.2:  Localization of Kin1-GFP in budding yeast cells.  Images are representative of 
localization to puncta (left), bud tip (center images), and bud neck (right).  Kin1-GFP was 

























Figure 2.3:  Quantification of localization of Kin1-GFP in bud14∆ cells.  Kin1-GFP was 
expressed from a low-copy plasmid.  Every budding cell for each strain was assessed in 
approximately 20 fields of view at 100x magnification.  The percentage of these budding cells 
displaying the indicated phenotype (P = puncta formation; BT = bud tip localization; BN = bud 
neck localization) was determined.  Five replicates were averaged in the above graph.  Data 
was collected at 100x magnification.  Localization of Kin1-GFP WT in kin1∆ kin2∆ strain is 
representative of Kin1-GFP WT localization in subsequent microscopy quantifications when 

























Figure 2.4:  Expression of mCherry-Bud14 from a low-copy plasmid rescues the localization 
phenotype of Kin1-GFP.  Quantification was performed as described in the legend for Figure 

























Figure 2.5:  mCherry-Bud14 and Kin1-GFP colocalize to sites of polarized growth in budding 
yeast cells.  Images are representative of results observed over three replicates. 
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and Bud14 using a yeast two-hybrid assay (Fig 2.6). In order to map the interacting region, 
we examined a series of Kin2 fragments in which the protein was truncated from either the 
N-terminus or C-terminus (Fig 2.7). We found that fragments harboring only the N-
terminal 459 residues (including the kinase catalytic domain) (Fig 2.8) or the C-terminal 
863 residues (including the KA1 domain) provided only background signals in the assay 
(Fig 2.9). All larger N- and C-terminal fragments of Kin2, to varying degrees, interacted 
with Bud14.  Because some N- and C-terminal fragments that provided positive signals did 
not overlap, our results implied that Bud14 interacts with multiple sites within the region 
comprising residues 459 – 863.  To more finely map the sites of interaction, we took 
advantage of the conserved nature of the Kin1/2-Bud14 interaction. Alignment of the 
sequences of Kin1 and Kin2 in S. cerevisiae with orthologs from yeast species as divergent 
as S. pombe revealed six conserved regions located in the central interacting portion of 
Kin1 and Kin2 (Fig 2.10).  To determine the importance of these regions, we made mutants 
that deleted each of them in the context of FL Kin2. Two of these mutants, deleting amino 
acids 749-756 and 801-833, greatly reduced the interaction between Kin2 and Bud14 (Figs 
2.11, 2.12).  When these two deletions were combined (to generate Kin2-∆749-756,∆801-
833), the two-hybrid signal was reduced to near background levels (Fig 2.12).   
To examine whether its interaction with Bud14 is required for proper localization 
of Kin1, we made the corresponding mutant (Kin1-∆709-716,∆775-806) in the context of 
the yeast GFP fusion construct. We indeed found that mutating the Bud14 binding sites 
substantially reduced Kin1 localization to puncta, the bud tip and bud neck (Fig 2.13). The 
partial localization of Kin1 to these sites may reflect residual weak interaction of Bud14 




















Figure 2.6: Full-length Kin2 and Bud14 interact in yeast two-hybrid analysis.  The indicated 
fusion proteins were expressed from high-copy plasmids.  Cultures were grown to mid-
exponential phase, and 5-fold dilutions were prepared starting at an OD600 of 0.5.  2 μL were 
spotted onto plates with histidine (+His) or without histidine but containing 3-aminotriazole, 



















Figure 2.7:  Truncation constructs used for yeast two-hybrid analysis.  Full-length Kin2 
(residues 1-1147) is depicted at the top for reference.  Red sections denote the catalytic kinase 













Figure 2.8:  Interaction of Gal4 AD-Kin2 N-terminal fragments with full-length Bud14.  
Samples were prepared as described in Figure 2.6. Only Gal4 AD-Kin2 constructs that 
included the N-terminal 863 residues were able to recapitulate the interaction between full-














Figure 2.9:  Interaction of Gal4 AD-Kin2 C-terminal fragments with full-length Bud14.  
Samples were prepared as described in Figure 2.6.  Gal4 AD-Kin2 C-terminal fragments 
required the region between residues 784 and 863 to recapitulate the interaction between full-















Figure 2.10:  Alignment of S. cerevisiae Kin1 (top row), S. cerevisiae Kin2 (middle), and S. 
pombe kin1 (bottom).  The N-terminal kinase domain and C-terminal KA1 domain are 
highlighted in yellow.  The six regions highlighted in red are conserved from S. cerevisiae to 
S. pombe and are located within the section of S. cerevisiae Kin1/2 determined to mediate the 



















Figure 2.11:  Deletion constructs used for yeast two-hybrid analysis.  Full-length Kin2 
(residues 1-1147) is depicted at the top for reference.  Red sections denote the catalytic kinase 













Figure 2.12:  Interaction of Gal4 AD-Kin2 deletion constructs with full-length Bud14.  
Samples were prepared as described in Figure 2.6.  Deletion of two regions (corresponding to 
residues 749-756 and 801-833 in Kin2) resulted in a decreased interaction between Kin2 and 
Bud14.  Combining these two deletions reduced the interaction to near background levels.  

























Figure 2.13:  Kin1-GFP lacking the two regions that interact with Bud14 are unable to 
localize properly to sites of polarized growth.  All three localization patterns (puncta 
formation, bud tip, and bud neck) were greatly reduced compared to Kin1-GFP WT (see 
Figure 2.3 for comparison).  Results are the average of three replicates. 
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Kin1 localization is partly dependent on its KA1 domain 
The kinase-associated 1 (KA1) domain of MARKs has been shown to both autoinhibit the 
kinase domain and to bind anionic phospholipids in a way that may promote localization 
to cellular membranes. To determine the extent to which the KA1 domain in Kin1 and Kin2 
may have similar roles, we first sought to identify likely functional residues within the 
domain.  Alignment of budding yeast Kin1 and Kin2 with the human MARK2 sequence 
revealed a cluster of conserved basic residues in the Kin1/Kin2 KA1 domains analogous 
to residues in MARK2 implicated in both kinase autoinhibition and in membrane 
association (H1040/K1042/K1043 of Kin1 and H1123/K1125/K1126 of Kin2).  To test for 
a role for the KA1 domain in controlling Kin1 localization, we mutated each of these 
residues to neutral polar amino acids (H1040Q/K1042S/K1043S, hereafter referred to as 
Kin1-KA1mut) in the context of the Kin1-GFP expression construct. Strikingly, mutation 
of the KA1 domain entirely eliminated formation of discrete puncta at the periphery (Fig 
2.14).  Localization to the bud tip was reduced about 50%, while bud neck localization did 
not change significantly.  We do note that the intensities of the signal at the bud neck and 
bud tip were reduced when compared to that of wild-type (WT) Kin1-GFP (Fig 2.15). 
 
Kin1 kinase activity is regulated by its KA1 domain independent of its localization or 
activation loop phosphorylation 
Kin1/2, like other kinases in the AMPKR family have a conserved Thr phosphorylation 
site in the activation loop that reportedly promotes kinase activity. To examine the impact 

























Figure 2.14:  Kin1-GFP KA1mut is unable to localize properly to sites of polarized growth.  
Puncta formation was completely abolished in the KA1 mutant (see Figure 2.3 for 
























Figure 2.15:  Kin1-GFP KA1mut bud tip and bud neck localization were reduced compared to 
WT.  Maximum intensity of individual cells was determined using ImageJ.  Approximately 
100 cells of both WT and the KA1 mutant were analyzed for each replicate.  Results are the 
average of three replicates. 
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residue in Kin1 (Thr302) or Kin2 (Thr281) and compared their activities to the WT kinases 
in vitro.  For these assays we purified GFP-tagged Kin1 and Kin2 expressed in yeast from 
their own promoters.  Unlike previous investigations of activation loop mutants that used 
generic substrates such as casein, we used a “primed” peptide substrate derived from the 
authentic Kin1/2 substrate Sec9. For both Kin1 and Kin2, we observed an approximately 
95% reduction in the kinase activity of the activation loop mutants relative to the WT 
kinases (Fig 2.16). These results indicate that substrate priming does not bypass a 
requirement for activation loop phosphorylation, as is the case for other kinases such as 
glycogen synthase kinase 3β.  We also observed no change in the localization of the GFP-
Kin1 T302A or GFP-Kin2 T281A mutants by fluorescence microscopy (Fig 2.17).   
While activation loop phosphorylation has been previously shown to enhance Kin1 
and Kin2 activity, the upstream kinase(s) responsible for phosphorylating Kin1/Kin2 have 
not been identified.  Budding yeast have three orthologs of the human MARK kinase 
LKB1:  Elm1, Sak1, and Tos3. All three kinases play a role in activating other members of 
the yeast AMPK family, either individually or in combination. To determine if these 
kinases are responsible for phosphorylation of the Kin2 activation loop, we purified GFP-
Kin2 from an elm1∆ sak1∆ tos3∆ strain lacking all three of the putative upstream activating 
kinases.  Similar to mutation of Thr281, we observed a more than 95% reduction in the 
activity of WT GFP-Kin2 purified from the elm1∆ sak1∆ tos3∆ strain relative to an 
otherwise isogenic WT strain (Fig 2.18).  We assessed Kin2 Thr281 phosphorylation by 
immunoblotting the purified protein with an antibody broadly reactive against the 
phosphorylated activation loops of AGC and CAMK group kinases. When isolated from 







Figure 2.16:  Activation loop phosphorylation is required for optimal Kin1/2 kinase activity.  
Point mutants of the putative activation loop threonine were generated for both Kin1 (T302A) 
and Kin2 (T281A).  Activity against a phosphopeptide substrate was determined as described 



















Figure 2.17:  Mutation of the activation loop threonine does not impact localization of Kin1-
























Figure 2.18:  Elm1/Sak1/Tos3 are responsible for activation of Kin1/2 in budding yeast.  
Wild-type and T281A GFP-Kin2 was purified from both wild-type yeast and a strain lacking 
Elm1, Sak1 and Tos3.  Samples were subjected to a kinase assay as described in methods.  
Results are the average of three replicates. 
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greatly reduced in the T281A mutant. Likewise, Kin2 isolated from the elm1∆ sak1∆ tos3∆ 
strain did not react with the activation loop antibody (Fig 2.19).  These results provide 
strong evidence that some combination of Elm1, Sak1 and Tos3 is responsible for the 
activation loop phosphorylation of Kin1 and Kin2 in vivo.   
Given previous reports that human MARKs are autoinhibited by their KA1 
domains, we examined whether the KA1 domain of Kin1/2 had the same function. WT and 
KA1 domain mutant GFP-Kin1 were purified from yeast and subjected to an in vitro kinase 
assay against the same phosphopeptide substrate used above.  We found a more than 
eightfold increase in the kinase activity of the Kin1-GFP KA1 mutant relative to WT Kin1-
GFP (Fig 2.20).  By contrast, we found no difference between WT Kin1 and Kin-KA1mut 
in the level of activation loop phosphorylation, suggesting that the KA1 domain restrains 
the kinase activity through a direct autoinhibitory interaction rather than by restricting 
activating phosphorylation.   
To assess any impact that association with Bud14 may have on the kinase activity 
of Kin1 and Kin2, we performed in vitro kinase assays on the Kin1-GFP-∆709-716,∆775-
806 construct. We observed a statistically significant, albeit minor, decrease in the kinase 
activity of the mutant in comparison to WT Kin1-GFP (Fig 2.21).  We did not observe any 
change in the activation loop phosphorylation state of the Kin1-GFP ∆709-716,∆775-806 
mutant relative to wild type Kin1-GFP.  We also performed a kinase assay on WT Kin1-
GFP that had been purified from both wild type and bud14∆ yeast cells.  In this case, we 
found no difference in either the kinase activity or activation loop phosphorylation of Kin1-





















Figure 2.19:  Elm1/Sak1/Tos3 are required for phosphorylation of the activation loop 
threonine of GFP-Kin2.  Wild-type and T281A GFP-Kin2 was immunoprecipitated from both 
wild-type yeast and a strain lacking Elm1, Sak1 and Tos3.  Phosphorylation was assessed 
using an antibody reactive to activation loop phosphorylation in AGC family kinases.  The 

























Figure 2.20:  The KA1 domain of Kin1/2 autoinhibits the activity of the kinase.  Kin1-GFP 
WT and KA1 mut were purified from kin1∆ kin2∆ yeast.  Kinase assays were preformed using 
a phosphopeptide substrate as described in methods.  The data is an average of three replicates.  

























Figure 2.21:  The Kin1-GFP ∆709-716,∆775-806 mutant has a minor significant impact on 
Kin1 kinase activity.  Kin1-GFP WT and ∆709-716,∆775-806 were purified from kin1∆ kin2∆ 
yeast.  Kinase assays were preformed using a phosphopeptide substrate as described in 
methods.The data is an average of three replicates.  The corresponding IP/immunoblot is 
























Figure 2.22:  Bud14 has no impact on Kin1 kinase activity.  Kin1-GFP WT was purified from 
both kin1∆ kin2∆ and kin1∆ kin2∆ bud14∆ yeast.   Kinase assays were preformed using a 
phosphopeptide substrate as described in methods.   The data is an average of three replicates.  
The corresponding IP/Immunoblot is representative of three replicates.         
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interaction with Bud14 nor localization to the cell periphery promote the kinase activity of 
Kin1.      
 
Kin1 activation loop phosphorylation, but not its localization to sites of polarized growth, 
promotes its function in the UPR  
We assessed the function of the various Kin1 mutants in the unfolded protein response 
(UPR) by performing growth assays in the presence of tunicamycin. We found that yeast 
expressing Kin1/2 with mutated activation loops were more sensitive to tunicamycin, 
suggesting that reducing their kinase activity decreases their capacity to promote the UPR  
(Fig 2.23). We further found that yeast expressing the KA1 domain mutant had increased 
resistance to tunicamycin. Because this mutation both hyperactivates Kin1 and causes its 
mislocalization, we further examined tunicamycin sensitivity of yeast expressing the Kin1-
∆709-716,∆775-806 mutant, which mislocalizes but has similar kinase activity to WT 
Kin1.  This mutant was not impaired in its ability to support growth in the presence of 
tunicamycin. Collectively, these results provide evidence that the localization of Kin1 and 
Kin2 has little to no impact on the ability of yeast to maintain a robust UPR.  They further 
suggest that the kinase activity of Kin1 and Kin2 correlates with their ability to act in the 
UPR.    
 
DISCUSSION 
Here we have shown that the localization of Kin1/2 is dependent on direct association with 
Bud14, which interacts with Kin1/2 through two discrete regions in the C-terminal region 
























Figure 2.23:  (Top) Kin1 function in the unfolded protein response correlates with its protein 
kinase activity.  UPR function was assessed by growth assay.  Mid-exponenetial phase cultures 
of Kin1-GFP were spotted on plates in 5-fold dilutions starting at an OD600 of 0.5.  2 μL 
aliquots were deposited onto plates with the indicated concentration of tunicamycin.  Results 
are representative of three replicates.  (Bottom) Representative  immunoblot showing protein 
levels.  Homocitrate synthase was used as a loading control.    
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sequence, a common recognition motif for SH3 domains71, 72.  We were intrigued by the 
possibility that the interaction was SH3-mediated, although attempts to analyze this using 
Bud14 with a mutated SH3 domain resulted in a high level of autoactivation in the yeast 
two-hybrid system (data not shown).  In light of previous observations that kin1 
phosphorylates tea4 in fission yeast, it is interesting to note that Bud14 contains several 
sites that nominally fit the preferred phosphorylation motif of Kin1/2, although none of 
these sites are conserved in fission yeast.  While I observed no change in Kin1/2 activation 
loop phosphorylation in a bud14∆ strain, it is possible that Bud14 facilitates 
dephosphorylation of other sites on Kin1/2 through recruitment of the Glc7 phosphatase.   
It is still unknown whether Bud14 is mutually dependent on Kin1/2 for localization to sites 
of polarized growth.  It is also unclear what role localization of Kin1/2 to sites of polarized 
growth plays in yeast cells generally.  It is possible that Kin1/2 regulate Bud14 (and by 
extension, Glc7), or perhaps Kin1/2 and the Bud14/Glc7 phosphatase complex act upon 
common substrates at sites of polarized growth.   
 As for a variety of orthologous kinases from human MARKs to C. elegans Par1 
and fission yeast kin1, we have shown that the KA1 domain in Kin1 is necessary to 
properly localize the kinase to sites of polarized growth, in particular being necessary for 
puncta formation.  Since I also found that the KA1 domain autoinhibits the kinase domain 
of Kin1/2, my results support a model by which KA1-domain binding to anionic 
phospholipids serves to both localize and activate the kinase.  Previous research on human 
MARKs also suggests that protein binding partners such as Gab1 serve to activate the 
kinase by disrupting the interaction between the KA1 domain and the kinase domain41.  
Given the lack of impact on kinase activity even in the absence of Bud14, the data suggest 
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that Bud14 does not play a similar role in yeast.  My research found that the autoinhibition 
of Kin1/2 by the KA1 domain was more dramatic than that found in the MARKs, where 
an approximately 2-fold impact on kinase activity has been reported.   
 The activation loop phosphorylation of Kin1/2 by Elm1/Sak1/Tos3 confirms that 
this trio of kinases activates all six members of the AMPK family in budding yeast25-29. 
Elm1/Sak1/Tos3 are partially redundant in their ability to activate other members of the 
AMPK family, although some members of the family exhibit a preference for one upstream 
activating kinase or another. Sak1, for example, is the primary activating kinase of Snf1, 
while Elm1 is responsible for activation of Gin4.  Further research will be needed to show 
the degree to which Elm1, Sak1, and Tos3 are redundant in activation of Kin1/2. 
We are interested in how Kin1/2 may participate in regulation of cell polarity in 
budding yeast cells.  Cell wall biosynthesis kinase (Cbk1) is an important regulator of cell 
growth, division, and establishment of cell polarity.  Cbk1 and Kin1/2 have overlapping 
patterns of localization to the bud neck and cortex and Cbk1 participates in cellular 
processes in common with other MARK/Par1/Kin orthologs, and notably Cbk1 was 
reported to interact with both Kin1 and Kin2 in two high throughput studies61, 63.  The more 
C-terminal region of Bud14 interaction on Kin1/2 (775-806 in Kin1, 801-833 in Kin2) 
contains sequence that perfectly matches the phosphorylation motif of Cbk1 (H-x-R-x-x-
pS at Ser799 on Kin1, Ser826 on Kin2) it is possible that phosphorylation at this site 
regulates the interaction between Kin1/2 and Bud1473.  In a preliminary study, I examined 
localization of Kin1/2 in a strain deficient for Cbk1 (cbk1∆ ssd1∆), but no significant defect 
in Kin1/2 localization was observed (not shown).  Mutational analysis of the putative Cbk1 
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site on Kin1/2 would be required to definitively rule out a regulatory interaction between 
Cbk1 and Kin1/2. 
   While we did not observe localization of Kin1/2 to the ER, it may be that they 
relocalize under conditions of ER stress. Alternatively, it is possible that a small pool of 
Kin1/2 undetectable by fluorescence microscopy is sufficient to promote the UPR.  It is 
also possible that Kin1/2 function in the UPR and exocytosis are connected to an overall 
role in cell polarization in ways that are not fully understood. 
 
EXPERIMENTAL PROCEDURES 
Antibodies – Antibodies used in this study and their sources were: anti-GFP (600-101-215; 
Rockland), anti-phospho-Kin1/2 (AGC kinase motif antibody, clone A1K4K; Cell 
Signaling Technology), anti-Gal4 activation domain (135398 14-7E10G101; Abcam). All 
other antibodies were from Santa Cruz Biotechnology:  anti-Gal4 DNA binding domain 
(RKC51 sc-510), anti-Fus3 (yC-19 sc-6773), and Anti-HCS (31F5). 
 
Plasmids - Low-copy plasmids expressing C-terminally GFP-tagged Kin1 and Kin2 
(pRS316-Kin1-GFP, pRS316-Kin2-GFP) were generous gifts from Peter Pryciak 
(University of Massachusetts).  The low copy plasmid expressing N-terminally GFP-
tagged Kin2 from its own promoter was previously described51. All point mutants made on 
these plasmid backgrounds were constructed by site-directed mutagenesis using the 


















































generously supplied by Chris Burd’s laboratory (Yale University).  pGBT9-Bud14 was 
produced by PCR amplification of the Bud14 coding sequence from the S. cerevisiae 
genomic tiling collection and inserted into pGBT9 using the EcoRI site.  Kin2 coding 
sequences for construction of the two-hybrid prey vectors were PCR amplified using 
pRS416-GFP-Kin2 as a template.  N-terminal Kin2 fragments were cloned into pGAD GH 
using the BamHI and XhoI sites; fragments of Kin2 C-terminus were cloned using an 
inserted 5’ EcoRI site (generated from pRS416: GFP-Kin2 by PCR amplification) and SalI. 
Full-length pGAD GH-Kin2 was created by inserting the Kin2-N457 fragment into pGAD 
GH-Kin2-C457.  All loop-out mutants were created by the QuikChange protocol using 
pGAD GH-Kin2 as a template.  pRS315-mCherry-Bud14 was produced by Gibson 
assembly using the pBG1442 vector generously provided by Bruce Goode as a template 
for the mCherry-Bud14 sequence.       
 
Yeast strains- Single deletion strains replacing the relevant gene with the kanMX cassette 
in the BY4741 background were from the yeast deletion collection (Stanford University) 
and purchased from Open Biosystems. The kin1∆ kin2∆ strain was described previously51. 
To construct the kin1∆ kin2∆ bud14∆ strain, we first disrupted KIN2 by insertion of a LEU2 
expression cassette in the bud14∆ single deletion strain, and then inserted the HIS3 gene at 
the KIN1 locus. 
 
In vitro kinase assays- Yeast strains expressing GFP-tagged Kin1 or Kin2 and their 





















growth (~0.8 OD600).  Approximately 500 OD600 units of cells were centrifuged at 4˚C, 
22,000 x g for 15 min, washed with dH2O, centrifuged again at 4˚C for 10 min at 6,000 x 
g, washed with dH2O, flash-frozen with liquid nitrogen, and stored at -80˚C for later use in 
kinase assays or immunoblots.  Cell pellets were thawed on ice and lysed in buffer 
containing 50 mM Tris, pH 7.5, 500 mM NaCl, 0.1% Triton X-100, 10% glycerol, 2 mM 
EGTA, 2 mM EDTA, 10 mM β-glycerophosphate, 2 mM NaF, 800 μM Na3VO4, 1 μM 
aprotinin, 10 μM leupeptin, 1 μM pepstatin A, and 2 mM DTT.  Cells were disrupted by 
beating with 400 mg of glass beads per 1 mL of lysate (10 x 1 min rounds of vortexing at 
4˚C), and the lysate was clarified by centrifugation at 4˚C for 10 min at 16,000 x g, 
transferred to a new Eppendorf tube, and protein concentration determined by Bradford 
assay. Equal amounts of protein were incubated with GFP-nanotrap beads (10 μL of packed 
beads per 1 mL of cell lysate, pre-equilibrated with lysis buffer) with rotation at 4˚C for 1-
4 hr. Beads were pelleted by centrifugation at 2,000 x g for 2 min at 4˚C, washed twice in 
lysis buffer, then washed twice in kinase assay buffer (50 mM HEPES pH 7.4, 10 mM 
MgCl2, 0.1% Tween-20, 1 mM DTT).     
The substrate peptide was previously reported and had the sequence 
RNSLNHSNpSTLNKKK, where pS indicates phosphoserine51. Peptide kinase assays were 
performed by suspending approximately 10 μL of packed GFP nanotrap beads loaded with 
GFP-tagged Kin1 or Kin2 (prepared as described above) in 20 μL of kinase assay buffer 
containing 100 μM peptide.  Reactions were initiated by adding ATP to 50 µM (with 0.05 
µCi/ml [γ-32P]-ATP) and transferring to a 30˚C heat block.  Samples were agitated by hand 
every 2-3 min to prevent settling of beads.  Aliquots (5 µL) were removed at 15 min 
intervals and spotted onto P81 phosphocellulose filters, which were immediately quenched 
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in 75 mM phosphoric acid. Filters were washed three times in the same solution, air dried, 
and analyzed by scintillation counting. Phosphate incorporation into peptides was 
calculated from standards consisting of varying amounts of reaction mixtures spotted onto 
filters that were left unwashed. 
 
Fluorescence microscopy- Cells were grown overnight in selective medium, and the 
density was adjusted by dilution into fresh medium to allow for ~4 doublings before harvest 
at mid-exponential phase growth (OD600 = 0.5-1.0).  To image cells, 1 mL of culture was 
centrifuged (2 min at 4K rpm, room temperature), the supernatant was aspirated, and the 
cells were resuspended in 10-20 μL of fresh selective medium.  The suspension (1-2 μL) 
was then deposited on a glass slide and visualized using a 100x magnification oil-
immersion objective on a Nikon Eclipse Ti microscope using μ-Manager software.  
Subsequent analysis was performed using ImageJ.   
 
Yeast two-hybrid analysis and growth assays- For two-hybrid analysis, yeast (strain PJ69-
4a) transformed with the indicated plasmids were grown to mid-exponential phase in 50 
mL of selective medium (SC-Leu-Trp).  Aliquots (2 μl) of a 5-fold dilution series (highest 
OD600 = 0.5) were spotted onto control agar plates (SC-Leu-Trp) and agar plates (SC-Leu-
Trp-His) containing the indicated concentrations of 3-aminotriazole (3AT), which were 
grown at 30 °C for 72–96 h.  The remainder of the cultures (~50 mL) was pelleted by 
centrifugation (5 min at 6,000 x g, 4˚C), washed with ddH2O, repelleted, snap frozen in 
liquid N2, and stored at -80˚C and subsequently used for immunoblot analysis.   
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For growth assays, the indicated yeast strains were grown to mid-exponential phase 
in 5 mL of selective medium. Dilutions were prepared as above and spotted onto SC-Ura 
agar plates containing the indicated concentrations of tunicamycin, which were grown at 
30 °C for 48–72h. For experiments examining tunicamycin sensitivity of Kin2 mutants, a 
portion of the culture was retained to prepare cell lysates for immunoblotting. The cells 
(~10 OD600 units) were collected by centrifugation, washed with ddH2O, repelleted, flash 
frozen in liquid N2, and stored at -80 °C.  
 
Immunoblotting- Cell lysates for immunoblots were prepared by mechanical disruption and 
TCA precipitation as described using 1 mL of 10% TCA extraction buffer (10 mM Tris, 
pH 8.0; 10% trichloroacetic acid; 25 mM NH4OAc; 1 mM Na2EDTA).  For samples 
harvested from yeast two-hybrid experiments, the protein pellet was then resuspended in 
300 μL of 500 mM Tris-HCl, pH 11.0 and 3% SDS, heated at 95˚C for 5 min, and 
centrifuged for 1 min at 16,000 x g at 4˚C.  240 μL of the lysate was combined with 80 μL 
of 4x SDS-PAGE loading buffer and boiled for 5 min. The remainder was used to 
determine protein concentration by BCA assay.  Equal amounts of protein were separated 
on a 7.5% acrylamide gel, transferred to a PVDF membrane overnight (18V for 15hr), and 
blocked in 5% milk for 1 hr at room temperature.  The samples were visualized on a LiCor 
Odyssey CLx using fluorophore-conjugated secondary antibodies.  Samples prepared from 
microscopy experiments were prepared in the same way as above with the exception of 
being resuspended in 150 μl of 100 mM Tris HCl, pH 11.0, and 3% SDS prior to boiling. 
 To immunoblot samples in pulldown experiments, approximately 10 μL of packed 
beads were suspended in 25 μL of 4x SDS-PAGE loading buffer, heated at 95˚C for 5 min, 
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separated on a 7.5% acrylamide Laemmli gel, and transferred to PVDF membranes. 
Membranes were blocked in 5% milk for 1 hr at room temperature and incubated overnight 
at 4˚C with primary antibodies diluted in 5% BSA.  Membranes were treated with 










Appendix: Phosphorylation-dependent regulation of 




 Scaffold proteins can perform important functions in the regulation of signal 
transduction cascades, such as providing specificity and promoting signal amplification. 
Post-translational modification of scaffold proteins provides a mechanism for crosstalk 
regulation between signaling pathways.  In this study I have shown that the budding yeast 
MAPK scaffold Ste5 is regulated by phosphorylation.  Ste5 is phosphorylated at Ser898 in 
vivo to stabilize the protein, thus promoting signal promulgation within the cell.  Although 
it is unclear what condition(s) are responsible for regulating phosphorylation at Ser898, my 




Signal transduction cascades are utilized by living cells to adapt to changes in their 
extracellular environment.  Scaffold proteins can have important roles in these processes 
by arranging components of signaling pathways to optimize relay of the signal75, 76.  In 
addition, scaffold proteins can contribute to dynamic regulation of signaling flux.  A key 
example of the essential role played by scaffold proteins in signal transduction involves 
mitogen-activated protein kinase (MAPK) cascades in the budding yeast Saccharomyces 
cerevisiae77, 78. The four yeast MAPK pathways control various functions including 
mating, filamentous growth, response to osmotic stress, and cell wall integrity.  The mating 
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and filamentous growth pathways in particular mediate distinct morphological changes 
under disparate conditions. Mating pathway activation prepares yeast for fusion with 
another cell and is optimal under nutrient rich conditions79, 80. By contrast filamentous 
growth leads to morphological changes that enable foraging for nutrients and is activated 
during starvation81.  Notably, while these two pathways lead to different cellular responses, 
they share key signaling intermediates82.  The mating pathway is activated by the binding 
of pheromone to the G protein-coupled receptors (GPCR) Ste2 and Ste3, while the 
filamentous growth pathway is activated by the cell surface mucin Msb2, which detects 
nutrient deficiency by an unknown mechanism77.  These signals are promulgated inside the 
cell by both heterotrimeric G-proteins (Gpa1/Ste4/Ste18) and small G-proteins (Cdc42) in 
the case of the mating pathway, while Cdc42 also plays an important role in activation of 
the filamentous growth pathway77, 81.  The two pathways share common MAPKKKKs 
(Ste20), MAPKKKs (Ste11), and MAPKKs (Ste7).  One key factor in mediating the 
differential cellular outputs is activation of the respective MAPKs, Fus3 in the case of the 
mating pathway, and Kss1 in the case of filamentous growth.  Activation of Fus3 versus 
Kss1 involves the scaffold protein Ste5, which diverts signaling preferentially to Fus3 and 
promotes transcription of mating pheromone-responsive genes83, 84. 
Ste5 is a large protein that contains binding sites for Ste11, Ste7, and Fus3, orienting 
the constituents of the MAPK cascade for activation by phosphorylation77, 85-87.  Ste5 also 
induces conformational changes in Fus3 to promote its phosphorylation by Ste788.  Ste5 
undergoes shuttling between the nucleus and cytoplasm under vegetative growth 
conditions89-91. Once a cell receives a pheromone signal, Ste5 is localized to the plasma 
membrane via a unique plasma membrane targeting domain, a pleckstrin homology (PH) 
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domain, and a binding site for the heterotrimeric G-protein Gβ subunit Ste492.  Adaptor 
proteins such as Ste50 also help to localize Ste5 at the cell membrane and facilitate Ste11 
activation by Ste20, thus promoting proper and efficient interplay of the crosstalk between 
the mating and filamentous growth pathways.   
Given the nutrient-regulated nature of both mating and filamentous growth, it 
stands to reason that signaling between the two pathways may be regulated by crosstalk 
with other nutrient-sensitive pathways. Indeed, Elm1, one of the three upstream activating 
kinases of the budding yeast AMP-activated protein kinase (AMPK) ortholog Snf1, may 
negatively regulate the mating pathway through phosphorylation of Gpa1, the Gα subunit 
associated with the Ste2/3 pheromone receptors93.  Likewise, deletion of Reg1, the 
phosphatase that dephosphorylates and inactivates Snf1 in the presence of glucose, leads 
to downregulation of the mating pathway. 
In this study, I investigate the possibility that the scaffold protein Ste5 serves to 
regulate nutrient-sensitive crosstalk between the mating pathway and filamentous growth 
pathway.  In particular, I explore phosphorylation of Ste5 at Ser898 as a potential means 
of regulating this crosstalk.  I found that Ste5 Ser898 is indeed phosphorylated in vivo, and 
that phosphorylation at this site stabilizes the protein. While phosphorylation of Ste5 at 
Ser898 does not appear to be glucose sensitive, under some conditions it appears to 
promote signaling through the mating pathway. Collectively, my studies reveal a new mode 






In vivo phosphorylation of Ste5 on Ser898 
I first assessed whether Ste5 Ser898 was phosphorylated in vivo.  Prior phosphoproteomic 
studies have detected phosphorylation of Ste5 at Ser898, and the residues surrounding 
Ser898 conform to the preferred phosphorylation motifs of both Snf1 and Tpk1/2/3, major 
nutrient-sensitive kinases (Fig A.1).  Attempts to generate a Ste5 phospho-Ser898 antibody 
from a commercial source were unsuccessful (not shown).  As an alternative, I used an 
anti-phospho PKA substrate antibody that recognizes the epitope R-R-x-pS/pT (hereafter 
called anti-phosphoSer898) on protein immunoprecipitated from cell lysates via a Myc 
epitope tag.  I was able to use this system to detect phosphorylation of Ste5 Ser898, and 
the reactivity of the antibody was greatly reduced when Ser898 was mutated to alanine (Fig 
A.2).      
 
Ser898 controls Ste5 protein levels 
Phosphorylation can impact protein stability and play a role in regulating cellular levels of 
a given protein.  I noted that mutation of Ser898 led to an approximately 50% decrease in 
the levels of Ste5 protein in the cell (see Fig A.2, Fig A.3).  Phosphorylation of Ser898 
stabilizes Ste5 and increases its half-life (Fig A.4).  Exposure to pheromone has been 
shown to increase the half-life of Ste5.  I found that, even after pheromone treatment, 
phosphorylation of Ser898 increased cellular levels of Ste5 protein by 50% (Fig A.5).  I 
also observed that pheromone treatment did not have an impact on Ser898 phosphorylation 
(see Fig A.5).  These results indicate that phosphorylation of Ste5 Ser898 controls Ste5 

















Figure A.1:  (Above) Schematic of Ste5 scaffold protein, to scale.  Amino acids important for 
interaction with proteins in the budding yeast MAPK cascade are depicted as black boxes.  
Regions of the protein that interact with lipids or participate in structural rearrangement are 
depicted underneath the protein.  Ser898 is denoted by a red dash.  (Below)  The Ste5 Ser898 




















Figure A.2:  Ste5 Ser898 is phosphorylated in vivo. Myc-Ste5 (WT and S898A) was 
expressed in ste5∆ cells on a low-copy plasmid and purified using a Myc antibody conjugated 
to agarose beads.  Phosphorylation was determined using a phospho-PKA substrate antibody. 













Figure A.3:  Ser898 controls Ste5 protein levels.  Mutation of Ser898 to alanine leads to a      
~ 50% decrease in Ste5 protein level. Myc-Ste5 was immunoprecipitated as described in 












Figure A.4:  Ser898 controls Ste5 protein stability.  The half-life of Ste5 was assessed by a 
cycloheximide pulse experiment.  Cultures of Myc-Ste5 WT and S898A mutant were grown to 
mid-exponential phase, treated with 1 μM cycloheximide, and aliquots were removed at the 
indicated times.  Homocitrate synthase was used as a loading control.  Results are the average 





















Figure A.5:  Ste5 Ser898 phosphorylation is not pheromone-responsive.  Myc-Ste5 was 
purified from ste5∆ cells and assessed for levels of Ste5 protein and for in vivo 
phosphorylation of Ser898.  Results are representative of three replicates.    
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Ste5 Ser898 is required for an optimal mating pheromone response 
As a measure of flux through the mating pathway, I examined phosphorylation of the 
MAPK Fus3 within its activation loop.  For the experiments described in this section, I 
expressed Ste5-Myc on a low-copy plasmid under the control of its native promoter in a 
ste5∆ strain.  I performed a time course monitoring Fus3 activation loop phosphorylation 
after stimulation with α-factor mating pheromone in yeast expressing either wild-type 
(WT) Ste5 or the Ste5-S898A mutant. I found that activation loop phosphorylation of Fus3 
was significantly reduced in the strain expressing the S898A mutant (Fig A.6).   
Activation of the budding yeast mating pathway ultimately leads to transcription of 
genes necessary for the mating process. I used a transcriptional reporter consisting of the 
FUS1 promoter placed upstream of the lacZ gene to measure the output of the mating 
pathway.  I found that mutation of Ser898 to Ala lead to an approximately 50% reduction 
in transcriptional activation of the mating pathway as indicated by β-galactosidase activity 
measured in cell lysates (Fig A.7) or intact cells (Fig A.8).  I observed a similar reduction 
in mating pathway activation when mutating Ser898 to asparagine (Fig A.9).  Mutation of 
Ser898 to a phosphomimetic Glu residue restored much of the WT transcriptional 
activation phenotype, suggesting that phosphorylation of Ser898 is vital to its role in 
promoting mating pathway signaling. To determine whether impaired pheromone signaling 
was due to reduced Ste5 protein levels, I examined the impact of increasing levels of Ste5-
S898A by expressing it from two separate plasmids.  I found that adding a second Ste5-
S898A plasmid restored WT levels of transcriptional activity (Fig A.10, Fig A.11) without 










Figure A.6:  Phosphorylation of the Fus3 activation loop.  Ste5∆ cells in exponential-phase 
growth were treated with 1 μM α-factor and aliquots were removed at the indicated time 
points.  Activated Fus3 (pFus3) was quantified against both total Fus3 levels and against a 
loading control (homocitrate synthase) by immunoblotting.  Results are the average of five 















Figure A.7:  Ser898 controls transcriptional activation of the yeast mating pathway.  β-
galactosidase activity was quantified in whole cell lysates prepared from WT and ste5∆ cells.  
Cells were exposed to 1 μM α-factor for one hour prior to harvest.  Results were normalized to 

















Figure A.8:  β-galactosidase activity was quantified in vivo in ste5∆ cells as described in 





















Figure A.9:  β-galactosidase activity of the S898N mutant was quantified in vivo in ste5∆ 
























Figure A.10:  Expressing Ste5 from two plasmids restored levels of Ste5 protein in cells to an 
intermediate level.  Levels of total Ste5 were determined using homocitrate synthase as a 


















Figure A.11:  Expressing Ste5 from two plasmids restored the transcriptional activation of the 
mating pathway to WT levels.  β-galactosidase activity of the S898A mutant expressed from 




There are three additional phosphorylatable residues in the immediate vicinity of 
Ser898 (Ser897, Ser900, and Ser901).  I examined the impact of mutation of each of these 
three residues to alanine individually and found that none of them had a profound impact 
on transcriptional activity in the mating pathway. However, combined mutation of all four 
Ser residues to Ala (Ste5-AAAA) modestly reduced the level of transcriptional activation 
in comparison to the single S898A mutation (Fig A.12).  Previous research had 
demonstrated that mutation of Arg895 to Gly impaired the ability of Ste5 to bind Ste794.  I 
mutated Arg895 to Gly under the assumption that this residue may additionally play a key 
role in recognition by the kinase that phosphorylates Ser898.  I found that the R895G 
mutant showed a significant decrease in transcriptional activation of the mating pathway, 
similar to the decrease I observed in the Ser898Ala mutant (Fig A.13).  
As another measure of signaling output from the mating pathway, I examined 
pheromone-induced cell cycle arrest using a halo assay.  I noted a marked reduction in cell 
cycle arrest as evident from a reduction in both the diameter and intensity of the halo for 
the S898A mutant (Fig A.14).  I found that mutation of Ser898 to the phosphomimetic Glu 
residue restored the cell cycle arrest phenotype of WT Ste5. Taken together, these results 
suggest that phosphorylation at Ser898 is required for optimal activation of the mating 
pathway and for maximal downstream responses. 
 
Mutation of Ste5 Ser898 at its endogenous locus impacts protein levels but not signaling 
output from the mating pathway  
The results above had been obtained by expressing Ste5 from a low-copy plasmid in a 


















Figure A.12:  Mutation of three serines adjacent to Ser898 lead to a minor additional decrease 
in transcriptional activation of the mating pathway relative to the S898A mutant.  β-
galactosidase activity of the AAAA mutant was quantified in vivo in ste5∆ cells.  Results are 



















Figure A.13:  Mutation of a key Arg residue adjacent to Ser898 leads to a significant decrease 
in transcriptional activation of the mating pathway equivalent to S898A mutation.  β-
galactosidase activity of the R895G mutant was quantified in vivo in ste5∆ cells.  Results are 






















Figure A.14:  Ste5 Ser898 phosphorylation is required for optimal mating response.  Wild-
type and ste5∆ yeast were transformed with the indicated plasmid and a halo assay was 
performed as described in methods.  The size and intensity of the halo is markedly decreased 
in the S898A mutant, while the halo produced by the S898E mutant is similar to or stronger 
than ste5∆: Myc-Ste5 WT.  The results are representative of three replicates.    
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expression of WT Ste5 from a plasmid did not result in full activation of the pathway as 
seen in STE5 cells. This suggested that the low copy plasmid may underexpress Ste5 
relative to expression from its endogenous locus.  To examine the requirement for 
phosphorylation of endogenously expressed Ste5, strains were engineered to incorporate a 
C-terminal Myc epitope tag at the endogenous STE5 locus, in conjunction with either the 
WT sequence, the S898A mutation, or the AAAA mutation.  I found that the S898A 
mutation reduced total Ste5 protein levels by roughly 50%, consistent with what I had 
observed when expressing Ste5 from a plasmid, confirming that Ser898 controls Ste5 
protein levels (Fig A.15).  However, I observed no change in pheromone-induced cell-
cycle arrest or activation of the transcriptional reporter between cells harboring WT Ste5 
and either Ste5-S898A or Ste5-AAAA.  These results suggest that while Ser898 indeed 
controls Ste5 protein levels, the endogenous levels of Ste5 protein are sufficient to support 
an optimal mating response even when its phosphorylation is prevented (Fig A.16).  
 
Ste5 Ser898 is phosphorylated by an as yet unidentified kinase  
I attempted to determine the kinase(s) responsible for phosphorylating Ste5 Ser898 in vivo 
by observing the phosphorylation of Ser898 in yeast strains harboring deletions of various 
kinases of interest.  These kinases were chosen based on having a phosphorylation site 
motif matching the sequence surrounding Ser898 and for their roles in nutrient sensing.  I 
found that Ser898 phosphorylation was unchanged in the absence of Snf1, under both high 
and low glucose conditions, suggesting that Snf1 plays no role in regulating this site.  I also 
examined other members of the AMPK family: Hsl1, Kcc4, and Gin4, and found that 





















Figure A.15:  Levels of endogenously expressed Ste5 are controlled by Ser898 
phosphorylation.  The S898A mutation reduces Ste5 protein levels by 50% when expressed 
under the control of the endogenous STE5 promoter.  Results are the average of three 




















Figure A.16:  When Ste5 is expressed under its endogenous promoter, Ser898 
phosphorylation does not impact transcriptional activation of the mating pathway.  Results of 
three replicates are depicted for each clone of Ste5 WT (n=8), Ste5 S898A mutant (n=7), and 
Ste5 AAAA mutant (n=5).  The x-axis represents clones, each of which was assayed four 
times.          
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a strain lacking all three upstream activating kinases for the AMPK family members, 
Elm1/Sak1/Tos3, and found no effect on Ser898 phosphorylation, ruling out redundant 
phosphorylation of Ser898 by multiple members of the Snf1 family.  Since the sequence 
surrounding Ser898 also matched the phosphorylation motif of Tpk1/2/3, the yeast 
homolog of PKA and another important glucose-sensitive kinase, I examined strains for 
each of these kinases and found no change in Ser898 phosphorylation.  Likewise, Ser898 
is not phosphorylated by Sch9, the budding yeast ortholog of mammalian S6 kinase and a 
major target of TOR phosphorylation, or Ste20, the MAPKKKK in the yeast mating 
pathway.  These results indicate that the kinase responsible for Ser898 phosphorylation 
may not be directed by the motif surrounding the site. 
 
Ste5 Ser898 is constitutively phosphorylated under a variety of culture conditions  
Given that Ser898 phosphorylation leads to a reduction in Ste5 protein levels, I wanted to 
find a condition that regulated phosphorylation at that site, as this may lead to a reduction 
in Ste5 that could impact mating efficiency.  I made use of our integrated S898A construct 
to examine the impact of glucose withdrawal, growth in alternative carbon sources, high 
salt conditions (0.4 M NaCl, 1 M NaCl), osmotic stress induced by sorbitol (0.5 M and 1 
M), and inhibition of protein synthesis using the mTORC1 inhibitor rapamycin (50 nM and 
200 nM).  As judged by both halo assays and transcriptional reporter assays, I was unable 
to discern any impact in the mating response under these various conditions.  
 Ste5 is known to shuttle between the nucleus and cytoplasm by means of a nuclear 
localization sequence (NLS).  Previous studies have shown a decrease in transcriptional 
activation of the mating pathway in yeast expressing Ste5 with a non-functional NLS.  I 
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mutated the NLS in both WT and S898A Ste5 to produce the Ste5-NLSmut and determined 
the impact of a functional NLS on transcriptional activation of the mating pathway.  I 
discerned no Ser898-specific impact on transcriptional activation from the NLSmut (data 
not shown).  This suggests that Ser898 does not influence nuclear shuttling via the NLS. 
 
DISCUSSION 
This study establishes a role for Ser898 phosphorylation in controlling the stability of the 
Ste5 scaffold protein in budding yeast.  The functions of scaffold proteins are critically 
dependent on their level of expression95. Insufficient concentrations of a scaffold protein 
will fail to bring signaling components into proximity, while too many copies can titrate 
components away from each other.  Interestingly, prior studies have suggested that under 
standard growth conditions, cellular Ste5 levels do not provide maximal output from the 
mating pathway96. Expression of Ste5 from promoters of varying strength indicated that 
endogenous levels of Ste5 are about 90% less than necessary to maximize signal output.  
Systems-level modeling suggested that there is a trade-off between the level of signal 
output and the dynamic range of the system.  The levels of Ste5 protein appear to be a key 
determinant in maintaining this balance, illustrating the importance of Ste5 scaffold levels 
in cellular decision-making. Further indication of the importance of Ste5 levels is suggested 
by the regulation of Ste5 stability in response to pheromone stimulation.  In cells that have 
not been exposed to pheromone, Ste5 is localized primarily in the nucleus, and the half-life 
of the protein is ~30 min due to ubiquitin-proteasome mediated degradation. Ste5 is 
shuttled between the nucleus and the cytoplasm, providing a pool of the scaffold available 
when a pheromone signal is received.  Upon pheromone stimulation, Ste5 translocates to 
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the plasma membrane, and is stabilized such that its half-life is in excess of two hours.  
Stabilization of Ste5 in response to pheromone treatment is likely important in propagation 
of signaling through the mating pathway as well as in preventing aberrant activation of the 
mating response in the absence of pheromone.  
 The notion that phosphorylation is vital to stabilization of Ste5 is not without 
precedent.  For example, degradation of Ste5 in the nucleus in the absence of pheromone 
is mediated by Cdc28 phosphorylation97-99. Cdc28 phosphorylation also prevents Ste5 
association with the plasma membrane, thus promoting the return of Ste5 to the nucleus 
for degradation98. Cdc28 involvement also ties Ste5 stability to the cell cycle, helping to 
enforce pheromone-induced cell-cycle arrest in G1 phase.  Upon pheromone stimulation 
and ensuing relocation to the plasma membrane, Ste5 is phosphorylated by various 
members of the budding yeast mating pathway, especially Fus3 but also Kss197, 100, 101.  
This constitutes a positive feedback loop that assists with Ste5 localization to the plasma 
membrane, thus preventing nuclear re-entry and further stabilizing Ste5 during mating 
pathway activation.    
 While I have confirmed that phosphorylation of Ste5 Ser898 controls the stability 
of the scaffold protein, it remains unclear what impact this phosphorylation has on mating 
pathway signaling with endogenous levels of Ste5.  It is possible that under certain 
conditions phosphorylation at Ser898 has a discernable impact on mating pathway 
activation.  For example, growth conditions in which Ste5 protein levels are reduced could 
require phosphorylation at Ser898 to promote mating pathway signaling.  While we were 
unable to identify such conditions in this study, one can envision untested stimuli that could 
impact the ability of a yeast cell to mate, such as exposure to extremes of temperature or 
 87 
pH.  Determination of such a condition would also facilitate the discovery of the kinase(s) 
responsible for phosphorylation of Ste5 Ser898, and yield insight into dynamic regulation 
of the budding yeast mating pathway.     
  
EXPERIMENTAL PROCEDURES 
Analysis of Ste5 phosphorylation- Yeast strains expressing Myc-tagged WT Ste5 and 
respective mutants were grown in 50 mL of selective medium to mid-exponential phase 
growth (OD600 = ~0.8).  Approximately 50 OD600 units of cells were centrifuged at 4˚C, 
22,000 x g for 15 min, washed with ddH2O, and re-centrifuged twice, flash-frozen with 
liquid nitrogen, and stored at -80˚C.  Cell pellets were thawed on ice and lysed in buffer 
containing 50 mM Tris, pH 7.5, 500 mM NaCl, 0.1% Triton X-100, 10% glycerol, 2 mM 
EGTA, 2 mM EDTA, 10 mM β-glycerophosphate, 2 mM NaF, 800 μM Na3VO4, 1 μM 
aprotinin, 10 μM leupeptin, 1 μM pepstatin A, and 2 mM DTT.  Cells were disrupted with 
400 mg of glass beads per 1 mL of lysate with 10 x 1 min rounds of vortexing at 4˚C. The 
lysate was clarified by centrifugation at 4˚C for 10 min at 16,000 x g, and protein 
concentration determined by Bradford assay. Equal amounts of protein were incubated 
with 20 μL of packed agarose beads bound to anti-Myc antibody (ThermoFisher, #20168) 
per 1 mL of cell lysate, pre-equilibrated to lysis buffer and mixed by rotation at 4˚C for 4 
hr. Beads were pelleted by centrifugation at 2,000 x g for 2 min at 4˚C, and washed twice 
in lysis buffer in preparation for immunoblotting. Packed beads were suspended in 25 μL 
of 4x SDS-PAGE loading buffer for 20 μL of packed beads, heated at 95˚C for 5 min, and 
separated on a 7.5% polyacrylamide Laemmli gel, and transferred to PVDF membranes. 
Membranes were blocked in 5% milk for 1 hr at room temperature (RT) and incubated 
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overnight at 4˚C with primary antibodies diluted in 5% BSA.  Membranes were treated 
with fluorophore-conjugated secondary antibodies and visualized on a LiCor Odyssey CLx 
system. 
For samples used in experiments to investigate putative kinases that phosphorylate 
Ste5 Ser898, cultures were grown in 400 mL of selective media to mid-exponential phase 
growth and harvested by quenching in TCA (final concentration 20%) for 20 min at 4˚C. 
Cells were centrifuged at 4˚C, 22,000 x g for 15 min, and washed twice with ddH2O.  
Samples were prepared for immunoprecipitation and immunoblotting as above.   
 
Cell growth, lysis and immunoblotting- Yeast cultures were grown to mid-exponential 
phase in the appropriate selective media and treated with the indicated concentration of 
cycloheximide (for analysis of Ste5 stability) or α-factor (for analysis of Fus3 
phosphorylation). At the indicated time points, the necessary amount of OD600 units of cells 
(50 OD units for analysis of Ste5 levels or 5 OD units for analysis of Fus3 phosphorylation) 
were removed, centrifuged at 4˚C for 10 min at 6,000 x g, washed with ddH2O, flash-frozen 
with liquid nitrogen, and stored at -80˚C. Cell lysates were prepared by mechanical 
disruption and TCA precipitation in 1 mL of 10% TCA extraction buffer (10% TCA, 10 
mM Tris HCl pH 8.0, 25 mM NH4OAc, and 1 mM Na2EDTA)102.  Proteins were 
precipitated from the lysates by centrifugation at 4˚C, 16,000 x g, for 10 min.  The 
supernatant was aspirated, and the pellet was resuspended in 0.1 M Tris HCl, pH 11.0 and 
3% SDS, heated at 95˚C for 5 min, and centrifuged for 1 min at 4˚C, 16,000 x g.  The 
supernatant was removed for analysis, and a portion was used to determine protein 
concentration by BCA assay.  Equal amounts of protein were separated on polyacrylamide 
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gels (7.5% for Ste5 levels analysis or 10% for analysis of Fus3 phosphorylation) and 
analyzed by immunoblotting as described above. 
 
Strains- To epitope tag Ste5 at its endogenous locus, the tag coding sequence and HIS3 
cassette were PCR amplified from the plasmid pFA6a-6Gly-Myc-His3 with primers 
incorporating 48 – 49 nucleotide homology arms flanking the 3’ end of the STE5 coding 
sequence103. To introduce point mutations, the PCR product was used as a template for a 
second PCR reaction using mutagenic primers incorporating an additional 60 nucleotides 
of sequence upstream of the mutation site. Yeast (strain BY4741) were transformed with 
the PCR products and selected on SC-His media. Transformants were genotyped by colony 
PCR using primers flanking the 5’ and 3’ insertion sites. Introduction of the desired point 
mutations was confirmed by Sanger sequencing of the relevant PCR product.   
 
Plasmids- FUS1-lacZ fusion reporter plasmids and the His6-Myc-Ste5 from plasmid pCJ93 
were obtained from the laboratory of Jeremy Thorner. To produce pRS315-His6-Myc-Ste5, 
I subcloned the entire ORF into the BamHI site of pRS315. Subsequent mutations in Ste5 
were generated by site-directed mutagenesis using an Agilent QuikChange kit.   
 
Halo Assays- overnight yeast cultures were diluted to an OD600 of 1.0, and 1 mL was spread 
on SC-Leu-Ura plates.  After 1 hr, excess moisture was removed by pipette and 10 μL of 
ddH2O with the indicated concentration of α-factor pheromone was applied to 1 cm filter 


























Antibodies- antibodies used in this study and their sources were: anti-homocitrate synthase 
(Santa Cruz Biotechnology; 31F5), anti-Fus3 yC-19 (Santa Cruz Biotechnology; 6773), 
anti-GFP (600-101-215; Rockland).  All other antibodies used were from Cell Signaling 
Technologies: anti-myc (9B11) (for immunoblotting), anti-myc (71D10) (for 
immunoprecipitation), anti-phospho PKA substrate 100G7E (9624), anti-phospho p44/42 
(4370). 
 
Reporter Assays- For in vitro reporter assays, the indicated strains were grown overnight 
in SC-Leu-Ura media.  Samples were diluted to an OD600 of 0.1 and grown for 2-3 
population doublings, and α-factor was added to the indicated concentration for 1 hr. 
Subsequently, 5 OD600 units of cells were collected by centrifugation, washed with 500 μL 
of ddH2O, re-centrifuged and resuspended in 250 μL of lysis buffer (100 mM Tris pH 8.0, 
10% glycerol, 1 mM DTT, 2 mM PMSF). The suspension was flash frozen in liquid 
nitrogen and stored at -80 ˚C.  Cell lysates were prepared by mechanical disruption and 
clarified as described above.  A portion of the lysate was used to determine protein 
concentration by Bradford assay.  Assays were performed using the FluoReporter® 
lacZ/Galactosidase Quantitation Kit (ThermoFisher, #F-2905).   Equal amounts of protein 
were loaded in quadruplicate for each sample, and total volume was brought to 10 μL using 
reaction buffer (100 mM phosphate buffer, 1mM MgCl2, and 45 mM β-mercaptoethanol), 
and 100 μL of 3-carboxyumbelliferyl β-D-galactopyranoside (CUG) working solution 
(final concentration of CUG = 1.1 mM), shaken gently to mix, and incubated for 30 min in 
the dark at RT.  The reaction was quenched with 50 μL of 200 mM sodium carbonate and 
read in a plate reader (390 nm excitation, 460 nm emission). 
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 In vivo analysis of transcriptional reporter activity was performed as described104.  
Cultures were grown to early exponential phase (OD600 = ~0.1-0.2) in quadruplicate, and 
90 μL of cells were pipetted into each well of a 96-well plate containing either vehicle or 
α-factor at final concentrations ranging from 64 nM to 64 μM.  Plates were incubated in a 
30˚C shaker at 205 rpm for 90 min, and 20 μL of fluorescein di-β-D-galactopyranoside 
(FDG) reagent (0.5 mM FDG in 130 mM PIPES, 0.25% Triton X-100) was added to each 
well. Plates incubated at 30˚C for ~60 min, reactions were quenched by addition of 20 μL 
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